← All organizations
Highest phase reached
Phase 3
First clinical trial
Feb 10, 2017Last known activity
Feb 22, 2024
Timeline
2000s
- Jun 1, 2003
Beijing Mabworks Biotech Co., Ltd.— Founded
Drugs by trial phase (11 distinct, 15 trials)
Phase 3 (5 own, 0 via acquisition)
Indications
Recent trials (15)
- NCT06232096Lead sponsorPhase 1/Phase 2Feb 22, 2024
- NCT05806099Lead sponsorPhase 1/Phase 2Jun 28, 2023
- NCT05862233Lead sponsorPhase 3Jun 2, 2023
- NCT05796206Lead sponsorPhase 2/Phase 3May 26, 2023
- NCT05314010Lead sponsorPhase 3Aug 18, 2022
- NCT05398653Lead sponsorPhase 1/Phase 2Feb 24, 2022
- NCT07044115Lead sponsorPhase 1/Phase 2Nov 26, 2021
- NCT04965077Lead sponsorPhase 1Jul 31, 2021
- NCT04834024Lead sponsorPhase 3Apr 30, 2021
- NCT04671875Lead sponsorPhase 1Feb 28, 2021
- NCT04651348Lead sponsorPhase 1Dec 31, 2020
- NCT04110301Lead sponsorPhase 1/Phase 2Nov 30, 2019
- NCT03842085Lead sponsorPhase 1Apr 11, 2019
- NCT03196986Lead sponsorPhase 3Jul 1, 2017
- NCT04103905Lead sponsorPhase 1Feb 10, 2017
Details
- Founded
- Beijing, CN Jun 1, 2003
- Last known activity
- Feb 22, 2024